---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-22-005920"
form_type: "8-K"
ticker: "ZVSA"
cik: "0001859007"
company_name: "ZyVersa Therapeutics, Inc."
filed_at: "2022-02-08T23:59:59+00:00"
generated_at: "2026-06-27T10:17:00.104290+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Larkspur Health Acquisition units may separate into common stock and warrants starting Feb 10, 2022

## Summary
- Units trade as LSPRU; separated common stock as LSPR, warrants as LSPRW on Nasdaq.
- Separation effective February 10, 2022; holders must contact transfer agent Continental Stock Transfer.
- No fractional warrants will be issued; only whole warrants will trade separately.

## SEC filing metadata
- accession: 0001213900-22-005920
- form_type: 8-K
- ticker: ZVSA
- cik: 0001859007
- company_name: ZyVersa Therapeutics, Inc.
- filed_at: 2022-02-08T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1859007/000121390022005920/0001213900-22-005920-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1859007/000121390022005920/ea155040-8k_larkspur.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-22-005920
- JSON: https://secwatch.observer/filing/0001213900-22-005920.json
- Plain text: https://secwatch.observer/filing/0001213900-22-005920.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.